FDA Import Refusal 799-9141022-4/11/1 — Glaxo Smithkline Pharmaceuticals Ltd
The FDA refused shipment 799-9141022-4/11/1 from Glaxo Smithkline Pharmaceuticals Ltd (India) on Nov 6, 2020. The refused product falls under Drugs and Biologics — ANTIBIOTIC N.E.C.. Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Nov 6, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56YDA99 ANTIBIOTIC N.E.C.
- Charges
- 75